Daniel Trifiletti, MD
Radiation Oncology · Jacksonville, FLNPI 1326308073
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,173 of the $23,882 with a category attached, or 88.7%. 6 manufacturers reported payments, led by Boston Scientific at 47.5% of the total. Reporting peaked in 2024 at $17,328 and has fallen 74.2% since, to $4,473 in 2025. Among radiation oncology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $884.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$11K
- Servier Pharmaceuticals LLC$11K
- Telix Pharmaceuticals$833
- Elekta, Inc.$225
- Monteris Medical Corporation$140
- Elekta Pty Ltd$47
Across 68 payments — averaging $8567.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$309K
- Blue Earth Diagnostics$137K
- Novocure Inc.$136K
What the payments were for
- Consulting fees$21,17389%
- Travel & lodging$1,7087%
- Food & beverage$1,0014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 11 | $11,355 |
| Servier Pharmaceuticals LLC | 5 | $11,281 |
| Telix Pharmaceuticals | 6 | $833 |
| Elekta, Inc. | 3 | $225 |
| Monteris Medical Corporation | 1 | $140 |
| Elekta Pty Ltd | 1 | $47 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLINICAL TRIAL PRODUCT$3,500
- GENERAL - IO ABLATION$1,750
- Neuroblate$140
- Icon$114
- Perfection$114
- TheraSphere Y90 Glass Microspheres 10 GBq$105
How this compares
$23,882 in reported general payments places this provider in the 90th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 14 | $81 |
| Lorazepam | 15 | $20 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Jacksonville
- Bradford HoppeJacksonville$11K
- Scot AckermanJacksonville$8K
- Shravan KandulaOrlando$444K
- Martin KeischMiami Shores$319K
- Marcio FagundesMiami$274K
- Evan ThomasWinter Park$209K
- Rupesh KotechaMiami$208K
- John SylvesterLakewood Ranch$205K
- Ravi ShridharOrlando$192K
- Alan BrownFort Myers$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.